You are viewing the site in preview mode

Skip to main content

Advertisement

Table 1 Characteristics overall and by diagnostic categories

From: Post-partum trend in blood pressure levels, renal function and proteinuria in women with severe preeclampsia and eclampsia in Sub-Saharan Africa: A 6-months cohort study

Characteristics Overall Severe preeclampsia Eclampsia p
n 54 37 17  
Age, years (SD) 26.3 (6.6) 27.6 (6.5) 23.3 (5.9) 0.025
Married (%) 23 (42.6) 17 (45.9) 6 (35.3) 0.56
Weight, kg (SD) 76.9 (14.6) 78.4 (14.4) 73.6 (14.8) 0.27
Body mass index, Kg/m2 (SD) 26.3 (4.8) 26.7 (4.7) 25.4 (5.2) 0.37
Systolic blood pressure, mmHg (SD) 167.2 (19.6) 166.6 (16.9) 168.7 (25.1) 0.71
Diastolic blood pressure, mmHg (SD) 104.1 (17.6) 104.6 (17.2) 102.9 (19.0) 0.75
Personal history, n (%) 9 (16.7) 9 (24.3) 0 0.044
Family history, n (%) 2 (3.7) 2 (5.4) 0 >0.99
Gravidity, median (min-max) 1 (1–3) 2 (1–4) 1 (1–1) 0.018
Para, median (min-max) 1 (0–2) 1 (1–2) 1 (0–1) 0.007
Premature, median (min-max) 0 (0–1) 0 (0–1) 0 (0–1) 0.72
Aborted, median (min-max) 0 (0–1) 0 (0–1) 0 (0–1) 0.88
Alive, median (min-max) 1 (1–2) 1 (1–3) 1 (1–1) 0.0005
Primipartenity, n (%) 37 (68.5) 22 (59.4) 15 (88.2) 0.06
Single gestation, n (%) 49 (90.1) 34 (9.9) 15 (88.2) 0.64
Gestational age at diagnosis, week (SD) 34.3 (6.0) 34.8 (5.8) 33.3 (6.5) 0.42
Gestational age at delivery, week (SD) 36.9 (3.5) 37.6 (2.8) 35.4 (4.2) 0.028
Delivery – diagnosis time, day (median, min-max) 0 (0–20) 0 (0–20) 0 (0–17) 0.18
Time to delivery from diagnosis >1 week, n (%) 14 (25.9) 11 (29.7) 3 (17.6) 0.51
Vaginal delivery, n (%) 31 (57.4) 20 (54) 11 (64.7) 0.56
Birth weight, g (SD) 2732 (691) 2938 (586) 2286 (708) 0.0008
Foetal outcome, n (%)     <0.0001
 Death 10 (18.5) 2 (5.4) 8 (47)  
 Alive 44 (81.5) 35 (94.6) 9 (53)  
Treatment received     
 Methyl-dopa tablet, n (%) 47 (87) 31 (83.8) 16 (94.1) 0.41
 Nicardipine injection, n (%) 35 (64.8) 19 (51.3) 16 (94.1) 0.002
 Nicardipine tablet, n (%) 32 (59.2) 23 (62.2) 9 (52.9) 0.56
 Labetalol tablet, n (%) 4 (7.4) 3 (8.1) 1 (5.9) >0.99
 Diazepam injection, n (%) 5 (9.2) 0 5 (29.4) 0.002
 Clorazepam tablet, n (%) 10 (18.5) 4 (10.8) 6 (35.3) 0.06
 MgSO4 injection, n (%) 54 (100) 37 (100) 17(100) NA
Outcomes     
 Persisting hypertension at M3, n (%) 15 (27.8) 11 (29.7) 4 (23.5) 0.75
 Persisting hypertension at M6, n (%) 8 (14.8) 6 (16.2) 2 (11.8) >0.99
 Persisting proteinuria at M3, n (%) 17 (31.5) 8 (21.6) 9 (52.9) 0.03
 Persisting proteinuria at M6, n (%) 1 (1.8) 1 (2.7) 0 >0.99
 Persisting hypertension or proteinuria at M3, n (%) 26 (48.1) 16 (43.2) 10 (58.8) 0.38
 Persisting hypertension or proteinuria at M6, n (%) 9 (16.7) 7 (18.9) 2 (11.8) 0.70
  1. M – Month; SD – Standard deviation.